F-RETA 

F-RETA (Retatrutide) — Triple Receptor Agonist for Transformative Weight Loss

F-RETA is FS Labs’ precision formulation of Retatrutide — the world’s most advanced weight loss peptide and the first clinically studied triple receptor agonist to simultaneously activate GLP-1, GIP, and glucagon pathways. Where conventional single-agonist treatments hit a ceiling, F-RETA works across all three axes of metabolic control, delivering fat loss results that are simply not achievable through any other mechanism.

Engineered for those who are serious about body transformation, F-RETA represents a complete paradigm shift in weight management science. Available in 10 mg/ml (Total 30 mg) in a precise 3 ml pen by FS Labs.

Key Benefits

• Triple-Pathway Fat Loss — Simultaneously activates GLP-1, GIP, and glucagon receptors for unmatched, multi-axis fat reduction
• Significant Weight Loss — Clinically demonstrated to achieve greater weight reduction than single or dual-agonist alternatives
• Powerful Appetite Suppression — GLP-1 and GIP receptor activation dramatically reduces hunger and food intake
• Enhanced Fat Oxidation — Glucagon receptor activation boosts energy expenditure and accelerates fat burning
• Glycemic Control — Improves insulin sensitivity and regulates blood glucose for comprehensive metabolic health
• Lean Mass Preservation — Targets fat stores while supporting the retention of lean muscle tissue

F-RETA by FS Labs is not just a weight loss peptide — it’s a complete metabolic reset. For those who demand the most advanced science has to offer.